Opinion statement
Malignancies are increased in some types of solid organ transplant patients receiving immunosuppressive therapy and are a significant contributor to patient morbidity and mortality. There may be a 100-fold increase in the incidence of de novo neoplasia in this population. The risk of lymphoproliferative malignancies is well appreciated. In contrast, the risk of solid tumors with their consequent morbidity and mortality is less well known, probably because of their common occurrence in the general population. Lung cancer is the most common cause of cancer death in the United States; therefore, lung cancer in patients undergoing organ transplantation would be expected to occur frequently on the basis of chance alone. However, the lung cancer risk is approximately 20 to 25 times that of the general population, with an incidence of 0.28% to 4.1% in patients after heart and lung transplant. Risk factors thought to contribute include cigarette smoking, advanced age at transplantation, and chronic immunosuppressive therapy. The role of transplantation (and consequent therapy) in the development of lung cancer in this high-risk population remains unclear. As in the nontransplant population, adequate screening techniques are lacking, making early diagnosis and treatment a challenge. Despite close follow-up and routine imaging with chest radiography and CT, lung cancers continue to be discovered incidentally and at advanced stages. Treatment is similar to that of patients who are nontransplanted with similar stage, histology, and performance status.
Similar content being viewed by others
References and Recommended Reading
Ahmed Z, Marshall MB, Kucharczuk JC, et al.: Lung cancer in transplant recipients. Arch Surg 2004, 139:902–906.
Penn I: Post transplant malignancies. Transplant Proc 1999, 31:1260–1266.
Kim MS, Kim SI, Kim YS, et al.: De novo cancer in transplant recipients. Transplant Proc 1996, 28:1652–1655.
Vallejo GH, Romero CJ, deVicente JC: Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol 2005, 56:87–99. This comprehensive review identified neoplastic complications of liver transplantation and the lack of association between liver transplantation and bronchogenic carcinoma.
Penn I: Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993, 7:431–445. This review highlights and compares the neoplastic complications of multiple large renal transplant registries.
Pham SM, Kormos RL, Landrenau RJ, et al.: Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 1995, 60:1783–1789.
Goldstein DJ, Williams DL, Oz MC, et al.: De novo malignancies after cardiac transplantation. Ann Thorac Surg 1995, 60:1783–1789.
Collins J, Kazerooni EA, Lacomis J, et al.: Bronchogenic carcinoma after lung transplantation. Frequency, clinical characteristics, and imaging findings. Radiology 2002, 224:131–138. Multicenter study aimed at identifying radiologic findings and clinical manifestations of lung cancer in lung transplant recipients.
Flemming RH, Jennison SH, Naunheim KS: Primary bronchogenic carcinoma in the heart transplant recipient. Ann Thorac Surg 1994, 57:1300–1301.
Curtil A, Robin J, Tronc F, et al.: Malignant neoplasms following cardiac transplantation. Eur J Cardiothrac Surg 1997, 12:101–106.
Delcambre F, Purvot FR, Ramon P, et al.: Primary bronchogenic carcinoma in transplant recipients. Transplant Proc 1996, 28:2884–2885.
Sone S, Takashima S, Li F, et al.: Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998, 351:1242–1245.
Henschke CI, McCauley DI, Yankelevitz DF, et al.: Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999, 354:99–105.
DePerrot M, Wigle DA, Pierre AF, et al.: Bronchogenic carcinoma after solid organ transplantation. Ann Thorac Surg 2003, 75:367–371.
Tanigushi S, Cooper DK, Chaffin JS, et al.: Primary bronchogenic carcinoma in recipients of heart transplants. Transpl Int 1997, 10:312–316.
Mihalov ML, Gattuso P, Abraham K, et al.: Incidence of post transplant among 674 solid-organ transplant recipients at a single center. Clin Transplant 1996, 10:248–255.
Pedotti P, Cardiloo M, Rossini G, et al.: Incidence of cancer after kidney transplant: results from North Italy transplant program. Transplantation 2003, 76:1448–1451.
Anyanwu AC, Townsend ER, Banner NR, et al.: Primary lung carcinoma after heart or lung transplantation: management and outcome. J Heart Lung Transplant 2001, 20:1044–1053. Retrospective cohort illustrating risk factors for developing bronchogenic carcinoma, effects of immunosuppression, and treatment of lung cancer in heart transplant recipients.
Dorent R, Mohammandi S, Tezenas S, et al.: Lung cancer in heart transplant patients: a 16-year survey. Transplant Proc 2000, 32:2752–2754.
Arcasoy SM, Hersch C, Christie JD, et al.: Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant 2001, 20:1044–1053.
Hojo M, Takashi M, Maluccio M, et al.: Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999, 397:530–535. In vitro demonstration of tumor transformation and progression after cellular exposure to cyclosporine.
McAdams HP, Erasmus JJ, Palmer SM: Complications (excluding hyperinflation) involving the native lung after single lung transplantation: incidence, radiologic features, and clinical importance. Radiology 2001, 218:233–241.
Hamarti LB, Schulman LL, Austin JH: Lung nodules and masses after cardiac transplantation. Radiology 1993, 188:491–497.
Tollerud DJ, Clark JW, Brown LM, et al.: Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 1989, 139:194–198.
Heelan RT, Flehinger BJ, Melamed MR: Non-small cell lung cancer: results of the New York screening program. Radiology 1984, 151:289–293.
Muhm JR, Miller WE, Fontana RS, et al.: Lung cancer detected during a screening program using four-month chest radiographs. Radiology 1983, 148:609–615.
Choi YH, Leung AN, Miro S, et al.: Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings. J Thorac Imaging 2000, 15:36–40.
Kazerooni EA, Chow LC, Whyte RI, et al.: Preoperative examination of lung transplant candidates: value of chest CT compared with chest radiography. AJR Am J Roentgenol 1995, 165:1343–1348.
Kehinde EO, Petermann A, Morgan JD, et al.: Triple therapy and incidence of de novo cancer in renal transplant recipients. Br J Surg 1994, 81:985–986.
Jonas S, Rayes N, Neumann U, et al.: De novo malignancies after liver transplantation using tacrolimusbased protocols or cyclosporine-based quadruple immunosuppresssion with an interleukin 2 receptor antibody or antithymocyte globulin. Cancer 1997, 80:1140–1150.
Frezza EE, Fung JJ, van Thiel DH: Non lymphoid cancer after liver transplantation. Hepatogastroenterology 1997, 44:1172–1181.
Haagsma EB, Hagens VE, Schaapveld M, et al.: Increased cancer risk after liver transplantation: a populationbased study. J Hepatol 2001, 34:84–91.
Kelly DM, Sukru E, Stephen RG, et al.: Liver transplant recipients are not at increased risk for non-lymphoid solid organ tumors. Cancer 1998, 83:1237–1243.
Berringuer M, Prieto M, Bustamante M, et al.: Incidence of de novo neoplasms after liver transplantation. Med Clin 1998, 111:481–484.
Peyregene V, Ducerf C, Admam M, et al.: De novo cancer after orthotopic liver transplantation. Transplant Proc 1998, 30:1484–1485.
Jain AB, Yee LD, Nalesnik MA, et al.: Comparative incidence of de novo non-lymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998, 66:1193–1200.
Sanchez EQ, Marubashi S, Jung G, et al.: De novo tumors after liver transplantation: a single-institution experience. Liver Tranpl 2002, 8:285–291.
Xiol X, Guardiola J, Menindez S, et al.: Risk factors for development of de novo neoplasia after liver transplantation. Liver Tranpl 2001, 7:971–975.
Benlloch S, Berringuer M, Prieto M, et al.: De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years. Am J Transplant 2004, 4:596–604.
Briceno J, Lopez-Cillero P, Fraga E, et al.: Results of liver transplantation in a Spanish group: a report from the Cordoba unit. Clin Transpl 2001, 15:187–194.
Jaurrieta E, Casais L, Figueras J, et al.: Analysis of 500 liver transplantations at Bellvitge Hospital. Med Clin 2000, 115:521–529.
Bellamy CO, DiMartini AM, Ruppert K, et al.: Liver transplantation or alcoholic cirrhosis: long term follow-up and impact of disease occurrence. Transplantation 2001, 72:619–626.
Jimenez C, Rodriguez D, Marques E, et al.: De novo tumors after orthotopic liver transplantation. Transplant Proc 2002, 34:297–298.
Levy M, Backman L, Husberg B, et al.: De novo malignancy following liver transplantation: a single center study. Transplant Proc 1993, 25:1397–1399.
Schmilovitz-Weiss H, Mor E, Sulkes J, et al.: De novo tumors after liver transplantation: a single-center experience. Transplant Proc 2003, 35:665–666.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bellil, Y., Edelman, M.J. Bronchogenic carcinoma in solid organ transplant recipients. Curr. Treat. Options in Oncol. 7, 77–81 (2006). https://doi.org/10.1007/s11864-006-0034-5
Issue Date:
DOI: https://doi.org/10.1007/s11864-006-0034-5